
| Company Name | DeepTrace Technologies Srl |
| Founded | 2018 |
| Head office | Milan, Italy |
| Website | http://www.deeptracetech.com/ |
| Contact | info@deeptracetech.com |
Classification of risk of having ovarian cancer
TRACE4OC provides the woman's level of risk (very low risk or medium-high risk) of being affected with ovarian cancer at the date of the TRACE4OC-processed USI investigation of an adnexal mass, combined with the serum level test for Cancer Antigen 125 (CA-125), performed no earlier than and no later than one month from the USI study, and with the current woman's menopausal state (premenopausal or post menopause).
Best neuropsychological predictors, Best voxel-based map predictors overlayed on the subject gray matter, Cognitive, Functional and behavioral deficits of the subject, Mild cognitive impairment (MCI) subject risk score (low risk vs high risk) of being affected by or progressing to Alzheimer's disease dementia within 24 months, Subject gray matter volume and images with normative comparison
TRACE4AD provides the subject's level of risk (low or high risk) of having or progressing to Alzheimer's disease dementia within 24 months, by an automatic reading of the subject's brain gray matter obtained from a 3D structural T1-weighted MRI brain study, also in combination with subject's neuropsychological measures.